author_facet Vitti, Gerard
Hamilton, John A.
Vitti, Gerard
Hamilton, John A.
author Vitti, Gerard
Hamilton, John A.
spellingShingle Vitti, Gerard
Hamilton, John A.
Arthritis & Rheumatism
Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid
Pharmacology (medical)
Immunology
Rheumatology
Immunology and Allergy
author_sort vitti, gerard
spelling Vitti, Gerard Hamilton, John A. 0004-3591 1529-0131 Wiley Pharmacology (medical) Immunology Rheumatology Immunology and Allergy http://dx.doi.org/10.1002/art.1780310817 <jats:title>Abstract</jats:title><jats:p>Previous studies have shown that mononuclear cell–conditioned medium (MCCM), interleukin‐1 (IL‐1), and all‐<jats:italic>trans</jats:italic>‐retinoic acid rapidly stimulate, while glucocorticoids lower, the urokinase‐type plasminogen activator (u‐PA) activity of human synovial fibroblastlike cells. It is now reported that MCCM, recombinant human IL‐1α (rHuIL‐1α), rHuIL‐1β, and all‐<jats:italic>trans</jats:italic>‐retinoic acid elevate the u‐PA messenger RNA (mRNA) levels to a steady‐state value within 2 hours, while dexamethasone (10<jats:sup>−7</jats:sup><jats:italic>M</jats:italic>) inhibits this increase. For both situations, when the u‐PA activity is either stimulated or reduced, the changes in the u‐PA mRNA levels parallel the changes in the u‐PA activity, and it is suggested that modulation of gene transcription plays an important role.</jats:p> Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid Arthritis & Rheumatism
doi_str_mv 10.1002/art.1780310817
facet_avail Online
Free
finc_class_facet Chemie und Pharmazie
Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9hcnQuMTc4MDMxMDgxNw
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9hcnQuMTc4MDMxMDgxNw
institution DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
imprint Wiley, 1988
imprint_str_mv Wiley, 1988
issn 0004-3591
1529-0131
issn_str_mv 0004-3591
1529-0131
language English
mega_collection Wiley (CrossRef)
match_str vitti1988modulationofurokinasetypeplasminogenactivatormessengerrnalevelsinhumansynovialfibroblastsbyinterleukin1retinoicacidandaglucocorticoid
publishDateSort 1988
publisher Wiley
recordtype ai
record_format ai
series Arthritis & Rheumatism
source_id 49
title Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid
title_unstemmed Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid
title_full Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid
title_fullStr Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid
title_full_unstemmed Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid
title_short Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid
title_sort modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid
topic Pharmacology (medical)
Immunology
Rheumatology
Immunology and Allergy
url http://dx.doi.org/10.1002/art.1780310817
publishDate 1988
physical 1046-1051
description <jats:title>Abstract</jats:title><jats:p>Previous studies have shown that mononuclear cell–conditioned medium (MCCM), interleukin‐1 (IL‐1), and all‐<jats:italic>trans</jats:italic>‐retinoic acid rapidly stimulate, while glucocorticoids lower, the urokinase‐type plasminogen activator (u‐PA) activity of human synovial fibroblastlike cells. It is now reported that MCCM, recombinant human IL‐1α (rHuIL‐1α), rHuIL‐1β, and all‐<jats:italic>trans</jats:italic>‐retinoic acid elevate the u‐PA messenger RNA (mRNA) levels to a steady‐state value within 2 hours, while dexamethasone (10<jats:sup>−7</jats:sup><jats:italic>M</jats:italic>) inhibits this increase. For both situations, when the u‐PA activity is either stimulated or reduced, the changes in the u‐PA mRNA levels parallel the changes in the u‐PA activity, and it is suggested that modulation of gene transcription plays an important role.</jats:p>
container_issue 8
container_start_page 1046
container_title Arthritis & Rheumatism
container_volume 31
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792339351976280066
geogr_code not assigned
last_indexed 2024-03-01T15:46:43.832Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Modulation+of+urokinase%E2%80%90type+plasminogen+activator+messenger+rna+levels+in+human+synovial+fibroblasts+by+interleukin%E2%80%901%2C+retinoic+acid%2C+and+a+glucocorticoid&rft.date=1988-08-01&genre=article&issn=1529-0131&volume=31&issue=8&spage=1046&epage=1051&pages=1046-1051&jtitle=Arthritis+%26+Rheumatism&atitle=Modulation+of+urokinase%E2%80%90type+plasminogen+activator+messenger+rna+levels+in+human+synovial+fibroblasts+by+interleukin%E2%80%901%2C+retinoic+acid%2C+and+a+glucocorticoid&aulast=Hamilton&aufirst=John+A.&rft_id=info%3Adoi%2F10.1002%2Fart.1780310817&rft.language%5B0%5D=eng
SOLR
_version_ 1792339351976280066
author Vitti, Gerard, Hamilton, John A.
author_facet Vitti, Gerard, Hamilton, John A., Vitti, Gerard, Hamilton, John A.
author_sort vitti, gerard
container_issue 8
container_start_page 1046
container_title Arthritis & Rheumatism
container_volume 31
description <jats:title>Abstract</jats:title><jats:p>Previous studies have shown that mononuclear cell–conditioned medium (MCCM), interleukin‐1 (IL‐1), and all‐<jats:italic>trans</jats:italic>‐retinoic acid rapidly stimulate, while glucocorticoids lower, the urokinase‐type plasminogen activator (u‐PA) activity of human synovial fibroblastlike cells. It is now reported that MCCM, recombinant human IL‐1α (rHuIL‐1α), rHuIL‐1β, and all‐<jats:italic>trans</jats:italic>‐retinoic acid elevate the u‐PA messenger RNA (mRNA) levels to a steady‐state value within 2 hours, while dexamethasone (10<jats:sup>−7</jats:sup><jats:italic>M</jats:italic>) inhibits this increase. For both situations, when the u‐PA activity is either stimulated or reduced, the changes in the u‐PA mRNA levels parallel the changes in the u‐PA activity, and it is suggested that modulation of gene transcription plays an important role.</jats:p>
doi_str_mv 10.1002/art.1780310817
facet_avail Online, Free
finc_class_facet Chemie und Pharmazie, Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9hcnQuMTc4MDMxMDgxNw
imprint Wiley, 1988
imprint_str_mv Wiley, 1988
institution DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1
issn 0004-3591, 1529-0131
issn_str_mv 0004-3591, 1529-0131
language English
last_indexed 2024-03-01T15:46:43.832Z
match_str vitti1988modulationofurokinasetypeplasminogenactivatormessengerrnalevelsinhumansynovialfibroblastsbyinterleukin1retinoicacidandaglucocorticoid
mega_collection Wiley (CrossRef)
physical 1046-1051
publishDate 1988
publishDateSort 1988
publisher Wiley
record_format ai
recordtype ai
series Arthritis & Rheumatism
source_id 49
spelling Vitti, Gerard Hamilton, John A. 0004-3591 1529-0131 Wiley Pharmacology (medical) Immunology Rheumatology Immunology and Allergy http://dx.doi.org/10.1002/art.1780310817 <jats:title>Abstract</jats:title><jats:p>Previous studies have shown that mononuclear cell–conditioned medium (MCCM), interleukin‐1 (IL‐1), and all‐<jats:italic>trans</jats:italic>‐retinoic acid rapidly stimulate, while glucocorticoids lower, the urokinase‐type plasminogen activator (u‐PA) activity of human synovial fibroblastlike cells. It is now reported that MCCM, recombinant human IL‐1α (rHuIL‐1α), rHuIL‐1β, and all‐<jats:italic>trans</jats:italic>‐retinoic acid elevate the u‐PA messenger RNA (mRNA) levels to a steady‐state value within 2 hours, while dexamethasone (10<jats:sup>−7</jats:sup><jats:italic>M</jats:italic>) inhibits this increase. For both situations, when the u‐PA activity is either stimulated or reduced, the changes in the u‐PA mRNA levels parallel the changes in the u‐PA activity, and it is suggested that modulation of gene transcription plays an important role.</jats:p> Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid Arthritis & Rheumatism
spellingShingle Vitti, Gerard, Hamilton, John A., Arthritis & Rheumatism, Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid, Pharmacology (medical), Immunology, Rheumatology, Immunology and Allergy
title Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid
title_full Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid
title_fullStr Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid
title_full_unstemmed Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid
title_short Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid
title_sort modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid
title_unstemmed Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoid
topic Pharmacology (medical), Immunology, Rheumatology, Immunology and Allergy
url http://dx.doi.org/10.1002/art.1780310817